Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial

Study Questions:

What is the cost-effectiveness of percutaneous coronary intervention with drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for patients with diabetes mellitus and multivessel coronary artery disease in the FREEDOM trial?